Editorial on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care
Advances in resistant hypertension
Abstract
Resistant hypertension (RHTN) has historically been defined as high blood pressure (BP) that remains uncontrolled despite use of 3 or more antihypertensive agents from different classes, including ideally, a diuretic. In 2008, the first American Heart Association Scientific Statement on RHTN included a new category of “controlled RHTN” as high BP controlled on 4 or more antihypertensive agents (1).
